Clinical Trial: Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Somatropin (Norditropin) in Children With Growth Failure Associated With ICF Deficiency.

Brief Summary: This trial is conducted in the United States of America (USA). This is a 12 month study to determine if Norditropin is safe and effective in children with IGF deficiency.

Detailed Summary:
Sponsor: Novo Nordisk A/S

Current Primary Outcome: Change in height standard deviation score [ Time Frame: 12 months ]

Original Primary Outcome:

Current Secondary Outcome: 12 months change in height standard deviation score adjusted for parent height z-score

Original Secondary Outcome:

Information By: Novo Nordisk A/S

Dates:
Date Received: February 1, 2005
Date Started: May 2003
Date Completion:
Last Updated: January 17, 2017
Last Verified: January 2017